A 73-Year-Old Man with Advanced Renal Cell Carcinoma - Episode 3

COSMIC 313: Efficacy Data

Dr Rana McKay reviews key efficacy data from the COSMIC 313 trial and discusses factors that are considered when choosing between IO-TKI or IO-IO combinations.

EP. 1: Case Presentation: A 73-Year-Old Man with Advanced Renal Cell Carcinoma (RCC)
EP. 2: Efficacy and Quality of Life Data from 5-Year Follow-Up of CheckMate 214
Now Viewing
EP. 3: COSMIC 313: Efficacy Data
EP. 4: Cabozantinib, Nivolumab, and Ipilimumab: Rationale for Use
EP. 5: Advice for Community Oncologists Treating Patients with Advanced RCC